Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stevens

Showing results (161-170 of 295) with videos related to

Pageof 30
Sort By:
ACR Open Rheumatology|April 22, 2025
The Prognostic and Functional Impact of Multimorbidity in Systemic SclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Journal of Clinical Microbiology|March 29, 2013
A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region onlySusan C Aitken, Michelle Bronze, Carole L Wallis, et al.
Journal of the International AIDS Society|August 2, 2011
Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyLivio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, et al.
Clinical Rheumatology|July 23, 2020
Performance of the 2017 EUSTAR activity index in an scleroderma cohortLaura Ross, Wendy Stevens, Michelle Wilson, et al.
Rheumatology (Oxford, England)|February 17, 2024
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosisMatthew James Sinclair Parker, Adelle S Jee, Dylan Hansen, et al.
Autoimmunity|September 4, 2015
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisMichael G Whitfield, Robin M Warren, Vanessa Mathys, et al.
BMC Pulmonary Medicine|November 29, 2019
The economic burden of systemic sclerosis related pulmonary arterial hypertension in AustraliaKathleen Morrisroe, Wendy Stevens, Joanne Sahhar, et al.
AIDS (London, England)|January 26, 2016
Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programsPeter N Fonjungo, Saladin Osmanov, Joel Kuritsky, et al.
Pageof 30

Showing results (161-170 of 295) with videos related to

Sort By:
Pageof 30
ACR Open Rheumatology|April 22, 2025
The Prognostic and Functional Impact of Multimorbidity in Systemic SclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Journal of Clinical Microbiology|March 29, 2013
A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region onlySusan C Aitken, Michelle Bronze, Carole L Wallis, et al.
Journal of the International AIDS Society|August 2, 2011
Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyLivio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, et al.
Clinical Rheumatology|July 23, 2020
Performance of the 2017 EUSTAR activity index in an scleroderma cohortLaura Ross, Wendy Stevens, Michelle Wilson, et al.
Rheumatology (Oxford, England)|February 17, 2024
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosisMatthew James Sinclair Parker, Adelle S Jee, Dylan Hansen, et al.
Autoimmunity|September 4, 2015
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisMichael G Whitfield, Robin M Warren, Vanessa Mathys, et al.
BMC Pulmonary Medicine|November 29, 2019
The economic burden of systemic sclerosis related pulmonary arterial hypertension in AustraliaKathleen Morrisroe, Wendy Stevens, Joanne Sahhar, et al.
AIDS (London, England)|January 26, 2016
Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programsPeter N Fonjungo, Saladin Osmanov, Joel Kuritsky, et al.
Pageof 30